Christopher A. Berger

1.3k total citations · 1 hit paper
21 papers, 712 citations indexed

About

Christopher A. Berger is a scholar working on Infectious Diseases, General Health Professions and Epidemiology. According to data from OpenAlex, Christopher A. Berger has authored 21 papers receiving a total of 712 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Infectious Diseases, 10 papers in General Health Professions and 7 papers in Epidemiology. Recurrent topics in Christopher A. Berger's work include Tuberculosis Research and Epidemiology (9 papers), Mobile Health and mHealth Applications (8 papers) and HIV/AIDS Research and Interventions (5 papers). Christopher A. Berger is often cited by papers focused on Tuberculosis Research and Epidemiology (9 papers), Mobile Health and mHealth Applications (8 papers) and HIV/AIDS Research and Interventions (5 papers). Christopher A. Berger collaborates with scholars based in United States, Uganda and United Kingdom. Christopher A. Berger's co-authors include Davi da Silva Böger, Sadhna Diwan, Peter S. Millard, Adithya Cattamanchi, Achilles Katamba, Stavia Turyahabwe, Patricia Turimumahoro, Devika Patel, Rebecca Crowder and Amanda Sammann and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and PLoS Medicine.

In The Last Decade

Christopher A. Berger

20 papers receiving 637 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

KANO’S METHODS FOR UNDERSTANDING CUSTOMER-DEFINED QUALITY

1993 522 citations Christopher A. Berger, Davi da Silva Böger et al. Medical Entomology and Zoology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Christopher A. Berger United States	9	195	156	128	121	105	21	712
Stephanie Adams United States	15	89 0.5×	57 0.4×	63 0.5×	139 1.1×	121 1.2×	66	1.2k
Vincent K. Omachonu United States	13	100 0.5×	74 0.5×	74 0.6×	153 1.3×	23 0.2×	39	699
Sharon Williams United Kingdom	20	116 0.6×	72 0.5×	87 0.7×	229 1.9×	57 0.5×	95	1.5k
Guangyu Hu China	14	73 0.4×	57 0.4×	83 0.6×	236 2.0×	26 0.2×	42	698
Abdul Raziq Pakistan	11	315 1.6×	55 0.4×	56 0.4×	89 0.7×	90 0.9×	50	866
Jonathan Clark United States	14	199 1.0×	19 0.1×	50 0.4×	217 1.8×	71 0.7×	36	1.0k
Abinash Panda India	17	123 0.6×	32 0.2×	88 0.7×	22 0.2×	86 0.8×	58	763
Xiaofeng Ju China	12	219 1.1×	174 1.1×	117 0.9×	144 1.2×	40 0.4×	45	950
Bryan Orme United States	5	55 0.3×	37 0.2×	220 1.7×	127 1.0×	58 0.6×	8	964
Marcus Alexander United States	17	68 0.3×	42 0.3×	35 0.3×	51 0.4×	43 0.4×	48	901

Countries citing papers authored by Christopher A. Berger

Since Specialization

Citations

This map shows the geographic impact of Christopher A. Berger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher A. Berger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher A. Berger more than expected).

Fields of papers citing papers by Christopher A. Berger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher A. Berger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher A. Berger. The network helps show where Christopher A. Berger may publish in the future.

Co-authorship network of co-authors of Christopher A. Berger

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher A. Berger. A scholar is included among the top collaborators of Christopher A. Berger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher A. Berger. Christopher A. Berger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Crowder, Rebecca, Diana Babirye, Christopher A. Berger, et al.. (2025). Scale-up of 99DOTS for TB treatment supervision: an interrupted time series analysis. The International Journal of Tuberculosis and Lung Disease. 29(7). 306–311.

Aschmann, Hélène E., Christopher A. Berger, Noah Kiwanuka, et al.. (2024). Adverse Events Reported During Weekly Isoniazid-Rifapentine (3HP) Tuberculosis Preventive Treatment Among People With Human Immunodeficiency Virus in Uganda. Open Forum Infectious Diseases. 11(11). ofae667–ofae667. 1 indexed citations

Aschmann, Hélène E., Christopher A. Berger, Achilles Katamba, et al.. (2024). Preference for daily (1HP) vs. weekly (3HP) isoniazid-rifapentine among people living with HIV in Uganda. SHILAP Revista de lepidopterología. 1(2). 83–89. 1 indexed citations

Aschmann, Hélène E., et al.. (2024). Preferences of people living with HIV for features of tuberculosis preventive treatment regimens in Uganda: a discrete choice experiment. Journal of the International AIDS Society. 27(12). 2 indexed citations

Leddy, Anna M., Joseph Ggita, Christopher A. Berger, et al.. (2023). Barriers and Facilitators to Implementing a Digital Adherence Technology for Tuberculosis Treatment Supervision in Uganda: Qualitative Study. Journal of Medical Internet Research. 25. e38828–e38828. 4 indexed citations

Kiwanuka, Noah, Rebecca Crowder, Christopher A. Berger, et al.. (2023). Implementation, feasibility, and acceptability of 99DOTS-based supervision of treatment for drug-susceptible TB in Uganda. SHILAP Revista de lepidopterología. 2(6). e0000138–e0000138. 7 indexed citations

Huddart, Sophie, Rebecca Crowder, Christopher A. Berger, et al.. (2022). Adherence trajectory as an on-treatment risk indicator among drug-resistant TB patients in the Philippines. PLoS ONE. 17(11). e0277078–e0277078. 2 indexed citations

Cattamanchi, Adithya, Rebecca Crowder, Noah Kiwanuka, et al.. (2021). Digital adherence technology for tuberculosis treatment supervision: A stepped-wedge cluster-randomized trial in Uganda. PLoS Medicine. 18(5). e1003628–e1003628. 35 indexed citations

Semitala, Fred C., Christopher A. Berger, Achilles Katamba, et al.. (2021). Acceptance and completion of rifapentine-based TB preventive therapy (3HP) among people living with HIV (PLHIV) in Kampala, Uganda—patient and health worker perspectives. SHILAP Revista de lepidopterología. 2(1). 71–71. 8 indexed citations

10.

Patel, Devika, Christopher A. Berger, Joseph Ggita, et al.. (2020). Iterative Adaptation of a Tuberculosis Digital Medication Adherence Technology to Meet User Needs: Qualitative Study of Patients and Health Care Providers Using Human-Centered Design Methods. JMIR Formative Research. 4(12). e19270–e19270. 15 indexed citations

11.

Crowder, Rebecca, Noah Kiwanuka, Joseph Ggita, et al.. (2020). Study protocol and implementation details for a pragmatic, stepped-wedge cluster randomised trial of a digital adherence technology to facilitate tuberculosis treatment completion. BMJ Open. 10(11). e039895–e039895. 5 indexed citations

12.

Berger, Christopher A., Rebecca Crowder, Joseph Ggita, et al.. (2020). Variation in tuberculosis treatment outcomes and treatment supervision practices in Uganda. Journal of Clinical Tuberculosis and Other Mycobacterial Diseases. 21. 100184–100184. 7 indexed citations

13.

Chaka, Wendy, Christopher A. Berger, Stella Huo, et al.. (2020). Presentation and outcome of suspected sepsis in a high-HIV burden, high antiretroviral coverage setting. International Journal of Infectious Diseases. 96. 276–283. 8 indexed citations

14.

Berger, Christopher A., Narges Alipanah, Fayez Kheir, et al.. (2020). Summary for Clinicians: 2019 Clinical Practice Guideline Summary for the Treatment of Drug-Resistant Tuberculosis. Annals of the American Thoracic Society. 17(8). 911–917. 2 indexed citations

15.

Cattamanchi, Adithya, Christopher A. Berger, Priya B. Shete, et al.. (2019). Implementation science to improve the quality of tuberculosis diagnostic services in Uganda. Journal of Clinical Tuberculosis and Other Mycobacterial Diseases. 18. 100136–100136. 16 indexed citations

16.

Kao, Raymond, et al.. (2018). Utilization profile of the Canadian-led coalition Role 2 Medical Treatment Facility in Iraq: the growing requirement for multinational interoperability. Canadian Journal of Surgery. 61(6). S195–S202. 5 indexed citations

17.

Millard, Peter S., et al.. (2012). Open-source point-of-care electronic medical records for use in resource-limited settings: systematic review and questionnaire surveys. BMJ Open. 2(4). e000690–e000690. 22 indexed citations

18.

Diwan, Sadhna, et al.. (1997). Composition of the Home Care Service Package: Predictors of Type, Volume, and Mix of Services Provided to Poor and Frail Older People. The Gerontologist. 37(2). 169–181. 39 indexed citations

19.

Berger, Christopher A., et al.. (1993). KANO’S METHODS FOR UNDERSTANDING CUSTOMER-DEFINED QUALITY. Medical Entomology and Zoology. 2(4). 3–35. 522 indexed citations breakdown →

20.

Degoulet, Patrice, et al.. (1980). [A computerized medical record for the follow-up of hypertensive patients (author's transl)].. PubMed. 28(3). 185–8. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact